| Title | Japanese Journal of Cancer and Chemotherapy |
| Abbreviation | Jpn. J. Cancer Chemother. |
| Publication Type | Journal |
| Subject Area, Categories, Scope | Cancer Research (Q4); Medicine (miscellaneous) (Q4); Oncology (Q4) |
| h-index | 25 |
| Overall Rank/Ranking | 24604 |
| SCImago Journal Rank (SJR) | 0.116 |
| Impact Score | 0.11 |
| Publisher | Japanese Journal of Cancer and Chemotherapy Publishers Inc. |
| Country | Japan |
| ISSN | 03850684 |
| Best Quartile | Q4 |
| Coverage History | 1979-2022 |
Japanese Journal of Cancer and Chemotherapy is a journal covering the technologies/fields/categories related to Cancer Research (Q4); Medicine (miscellaneous) (Q4); Oncology (Q4). It is published by Japanese Journal of Cancer and Chemotherapy Publishers Inc.. The overall rank of Japanese Journal of Cancer and Chemotherapy is 24604. According to SCImago Journal Rank (SJR), this journal is ranked 0.116. SCImago Journal Rank is an indicator, which measures the scientific influence of journals. It considers the number of citations received by a journal and the importance of the journals from where these citations come. SJR acts as an alternative to the Journal Impact Factor (or an average number of citations received in last 2 years). This journal has an h-index of 25. The best quartile for this journal is Q4.
The ISSN of Japanese Journal of Cancer and Chemotherapy journal is 03850684. An International Standard Serial Number (ISSN) is a unique code of 8 digits. It is used for the recognition of journals, newspapers, periodicals, and magazines in all kind of forms, be it print-media or electronic. Japanese Journal of Cancer and Chemotherapy is cited by a total of 220 articles during the last 3 years (Preceding 2022).
The Impact IF 2022 of Japanese Journal of Cancer and Chemotherapy is 0.11, which is computed in 2023 as per its definition. Japanese Journal of Cancer and Chemotherapy IF is increased by a factor of 0.01 and approximate percentage change is 10% when compared to preceding year 2021, which shows a rising trend. The impact IF, also denoted as Journal impact score (JIS), of an academic journal is a measure of the yearly average number of citations to recent articles published in that journal. It is based on Scopus data.
Impact IF 2022 of Japanese Journal of Cancer and Chemotherapy is 0.11. If the same upward trend persists, Impact IF may rise in 2023 as well.
| Year | Impact IF |
|---|---|
| 2023/2024 | Coming Soon |
| 2022 | 0.11 |
| 2021 | 0.10 |
| 2020 | 0.09 |
| 2019 | 0.07 |
| 2018 | 0.07 |
| 2017 | 0.09 |
| 2016 | 0.09 |
| 2015 | 0.13 |
| 2014 | 0.12 |
Japanese Journal of Cancer and Chemotherapy has an h-index of 25. It means 25 articles of this journal have more than 25 number of citations. The h-index is a way of measuring the productivity and citation impact of the publications. The h-index is defined as the maximum value of h such that the given journal/author has published h papers that have each been cited at least h number of times.
The ISSN of Japanese Journal of Cancer and Chemotherapy is 03850684. ISSN stands for International Standard Serial Number.
An ISSN is a unique code of 8 digits. It is used for the recognition of journals, newspapers, periodicals, and magazines in all kind of forms, be it print-media or electronic.
The overall rank of Japanese Journal of Cancer and Chemotherapy is 24604. According to SCImago Journal Rank (SJR), this journal is ranked 0.116. SCImago Journal Rank is an indicator, which measures the scientific influence of journals. It considers the number of citations received by a journal and the importance of the journals from where these citations come.
| Year | SJR |
|---|---|
| 2023/2024 | Coming Soon |
| 2022 | 0.116 |
| 2021 | 0.115 |
| 2020 | 0.121 |
| 2019 | 0.116 |
| 2018 | 0.118 |
| 2017 | 0.119 |
| 2016 | 0.120 |
| 2015 | 0.127 |
| 2014 | 0.121 |
| Year | Ranking |
|---|---|
| 2023/2024 | Coming Soon |
| 2022 | 24604 |
| 2021 | 23808 |
| 2020 | 26860 |
| 2019 | 25396 |
| 2018 | 25691 |
| 2017 | 25472 |
| 2016 | 25284 |
| 2015 | 23564 |
| 2014 | 24286 |
Japanese Journal of Cancer and Chemotherapy is published by Japanese Journal of Cancer and Chemotherapy Publishers Inc.. It's publishing house is located in Japan. Coverage history of this journal is as following: 1979-2022. The organization or individual who handles the printing and distribution of printed or digital publications is known as Publisher.
Visit the official website of the journal/conference to check the further details about the call for papers.
The IS0 4 standard abbreviation of Japanese Journal of Cancer and Chemotherapy is Jpn. J. Cancer Chemother.. This abbreviation ('Jpn. J. Cancer Chemother.') is well recommended and approved for the purpose of indexing, abstraction, referencing and citing goals. It meets all the essential criteria of ISO 4 standard.
ISO 4 (International Organization for Standardization 4) is an international standard that defines a uniform and consistent system for abbreviating serial publication titles and journals.
If your research field is/are related to Cancer Research (Q4); Medicine (miscellaneous) (Q4); Oncology (Q4), then please visit the official website of this journal.
The acceptance rate/percentage of any academic journal/conference depends upon many parameters. Some of the critical parameters are listed below.
It is essential to understand that the acceptance rate/rejection rate of papers varies among journals. Some Journals considers all the manuscripts submissions as a basis of acceptance rate computation. On the other hand, few consider the only manuscripts sent for peer review or few even not bother about the accurate maintenance of total submissions. Hence, it can provide a rough estimation only.
The best way to find out the acceptance rate is to reach out to the associated editor or to check the official website of the Journal/Conference.
Japanese Journal of Cancer and Chemotherapy latest impact IF is 0.11. It's evaluated in the year 2022. The highest and the lowest impact IF or impact score of this journal are 0.13 (2015) and 0.07 (2019), respectively, in the last 9 years. Moreover, its average IS is 0.1 in the previous 9 years.
The Japanese Journal of Cancer and Chemotherapy has an SJR (SCImago Journal Rank) of 0.116, according to the latest data. It is computed in the year 2023. In the past 9 years, this journal has recorded a range of SJR, with the highest being 0.127 in 2015 and the lowest being 0.115 in 2021. Furthermore, the average SJR of the Japanese Journal of Cancer and Chemotherapy over the previous 9-year period stands at 0.1.
The latest h-index of the Japanese Journal of Cancer and Chemotherapy is 25.
The Japanese Journal of Cancer and Chemotherapy is published by the Japanese Journal of Cancer and Chemotherapy Publishers Inc., with its country of publication being the Japan.
The Japanese Journal of Cancer and Chemotherapy is currently ranked 24604 out of 27955 Journals, Conferences, and Book Series in the latest ranking. Over the course of the last 9 years, this journal has experienced varying rankings, reaching its highest position of 23564 in 2015 and its lowest position of 26860 in 2020.
The standard ISO4 abbreviation for the Japanese Journal of Cancer and Chemotherapy is Jpn. J. Cancer Chemother..
Japanese Journal of Cancer and Chemotherapy is classified as a journal that the Japanese Journal of Cancer and Chemotherapy Publishers Inc. publishes.
The Japanese Journal of Cancer and Chemotherapy encompasses the following areas:
For a more comprehensive understanding of its scope, check the official website of this journal.
The Japanese Journal of Cancer and Chemotherapy is assigned the following International Standard Serial Numbers (ISSN): 03850684.
The best quartile for the Japanese Journal of Cancer and Chemotherapy is Q4 (2022).
The Japanese Journal of Cancer and Chemotherapy coverage history can be summarized as follows: 1979-2022.
| Journal/Conference/Workshop/Book Title | Type | Ranking | Publisher | h-index | Impact Score |
|---|---|---|---|---|---|
| Journal of Academic Ethics | journal | 8920 | Springer Netherlands | 26 | 2.28 |
| European Union Politics | journal | 2250 | SAGE Publications Ltd | 72 | 2.64 |
| Proceedings of the International Semiconductor Conference, CAS | conference and proceedings | 25734 | Institute of Electrical and Electronics Engineers Inc. | 16 | 0.00 |
| Epigenetics | journal | 2362 | Landes Bioscience | 105 | 4.11 |
| International Journal of Pest Management | journal | 13393 | Taylor and Francis Ltd. | 50 | 1.50 |
| Clinical Interventions in Aging | journal | 4777 | Dove Medical Press Ltd. | 96 | 3.57 |
| Communications in Computational Physics | journal | 3847 | Global Science Press | 64 | 2.63 |
| PLoS ONE | journal | 5108 | Public Library of Science | 404 | 3.75 |
| Innovations in Pharmaceutical Technology | trade journal | 26994 | Samedan Ltd | 9 | 0.00 |
| Integrative Psychological and Behavioral Science | journal | 14074 | Springer New York | 39 | 1.15 |
| Year | Impact Score (IS) |
|---|---|
| 2023/2024 | Coming Soon |
| 2022 | 0.11 |
| 2021 | 0.10 |
| 2020 | 0.09 |
| 2019 | 0.07 |
| 2018 | 0.07 |
| 2017 | 0.09 |
| 2016 | 0.09 |
| 2015 | 0.13 |
| 2014 | 0.12 |
